Efficacy and Safety of Intranasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults with Diabetes
What is the purpose of this trial?
The primary objective of this study is to assess the effectiveness and safety of 3 mg glucagon (AMG504-1) administered as a puff into the nose compared with commercially-available glucagon given by injection.
- 18 Years - 64 Years
- Jaeb Center for Health Research
- Last Updated:
- Study HIC#: